UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049277
Receipt number R000056116
Scientific Title Measurement of anaerobic threshold and respiratory compensation point using blood oxygen saturation
Date of disclosure of the study information 2022/11/01
Last modified on 2023/04/24 17:18:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of simple measurement method of anaerobic threshold and respiratory compensation point

Acronym

Examination of simple measurement method of anaerobic threshold and respiratory compensation point

Scientific Title

Measurement of anaerobic threshold and respiratory compensation point using blood oxygen saturation

Scientific Title:Acronym

Measurement of anaerobic threshold and respiratory compensation point using blood oxygen saturation

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination of measurement method of anaerobic threshold and respiratory compensation point using blood oxygen saturation

Basic objectives2

Others

Basic objectives -Others

Exercise intensity

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Anaerobic threshold and respiratory compensation point

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Exercise

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1. Men and women between the ages of 20 and 65.
2. BMI of 18.5 or more and less than 30.0 kg/m2.

Key exclusion criteria

1. Subjects with severe respiratory disease, liver diseases, digestive organ diseases, kidney diseases and heart diseases.
2. Subjects who are resistant to high-intensity exercise.
3. Subjects who intend to become pregnant or lactating.
4. Subjects infected with coronavirus (COVID-19) or who fall under close contact with infected persons
5. Subjects with exercise-induced diseases such as exercise-induced arrhythmia and exercise-induced anaphylaxis and exercise equipment disorders
6. Subjects who are judged as unsuitable for the study by the investigator for other reason.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yuri
Middle name
Last name Ishii

Organization

FANCL Corporation

Division name

Research Institute, Health science research center

Zip code

244-0806

Address

12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa

TEL

045-820-3419

Email

yuishii@fancl.co.jp


Public contact

Name of contact person

1st name Masatsugu
Middle name
Last name Abe

Organization

New Business Division

Division name

New Business Promotion Department

Zip code

231-8528

Address

89-1 Yamashita-cho, Naka-ku, Yokohama

TEL

045-226-1044

Homepage URL


Email

abe_masatsugu@fancl.co.jp


Sponsor or person

Institute

FANCL Research Institute

Institute

Department

Personal name



Funding Source

Organization

FANCL Research Institute

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

FANCL Corporation Clinical Research Ethics Committee

Address

12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan

Tel

045-820-3657

Email

akihide_nisihara@fancl.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

34

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 09 Month 21 Day

Date of IRB

2022 Year 09 Month 28 Day

Anticipated trial start date

2022 Year 10 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 05 Month 01 Day

Date analysis concluded

2023 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2022 Year 10 Month 20 Day

Last modified on

2023 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056116


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name